The US Food and Drug Administration (FDA) has approved Deciphera Pharmaceuticals’ Romvimza (vimseltinib) to treat adults with ...

The University of Bath has received a £3.5 million Wellcome grant to study cognitive decline and premature brain ageing in ...

Carbogen Amcis has appointed Stephan Fritschi, who is currently serving as the company’s Chief Alliance Officer and Deputy ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer to improve screening, diagnosis and ...

A new UK study has highlighted the critical role of GP data in understanding atrial fibrillation (AF), the most common form ...

After two years of treatment with bimekizumab, 53.1% of patients experienced mild disease compared to none at baseline.

Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

NHS England has launched its first-ever breast cancer awareness campaign aimed at highlighting the benefits of screening for ...

Amlenetug received Orphan Drug Designation (ODD) from the US FDA in April 2024, the EMA in May 2021 and SAKIGAKE designation ...

Baxter International has appointed Brent Shafer, who has been serving as the company’s Lead Independent Director, as Chair ...

Global biotechnology leader CSL has announced that the European Commission (EC) has approved ANDEMBRY (garadacimab), the ...